Cancer Therapies and Osteoporosis

 

THE HIDDEN COST OF SURVIVAL:

How Cancer Therapies Accelerate Bone Loss in Men

By: Lennard M. Goetze, Ed.D

 

Cancer treatment has made extraordinary strides—extending life, improving outcomes, and transforming once-fatal diagnoses into manageable conditions. Yet beneath these successes lies a quieter, often overlooked consequence: the progressive weakening of the skeletal system. For many male cancer patients, especially those undergoing aggressive or long-term therapies, the risk of osteoporosis is not incidental—it is biologically driven, predictable, and, in many cases, preventable with early awareness.

 

A Silent Shift in Bone Biology

Healthy bone is not static. It is a dynamic tissue constantly undergoing remodeling—a balance between bone formation (by osteoblasts) and bone resorption (by osteoclasts). Cancer therapies disrupt this balance. When the body is exposed to certain drugs or hormone-altering treatments, bone breakdown begins to outpace repair, leading to reduced density, compromised structure, and ultimately, fragility.

 

In men, this process is often intensified by hormonal disruption. Testosterone plays a crucial role in maintaining bone strength. When cancer treatments interfere with hormone production or signaling, the skeletal system becomes one of the earliest and most significantly affected targets.

 

 

Androgen Deprivation Therapy: A Double-Edged Sword

Among the most well-documented contributors to bone loss in men is androgen deprivation therapy (ADT), commonly used in the treatment of prostate cancer. By design, ADT suppresses testosterone to slow tumor growth. However, this same mechanism accelerates skeletal deterioration.

 

Without adequate testosterone, the normal cycle of bone renewal becomes unbalanced. Bone resorption increases, while formation declines. Over time, this leads to measurable declines in bone mineral density (BMD), often within the first year of therapy. Longitudinal observations have shown that men on prolonged ADT can face a dramatic escalation in osteoporosis risk, along with a corresponding rise in fracture incidence.

 

This creates a paradox: while ADT may control cancer progression, it simultaneously compromises the structural integrity that supports mobility, independence, and overall quality of life.

 

Chemotherapy and Direct Bone Toxicity

Beyond hormonal therapies, several chemotherapeutic agents exert direct toxic effects on bone tissue. Drugs such as methotrexate and ifosfamide interfere with cellular replication—not only in cancer cells but also in the bone-forming osteoblasts. This suppression reduces the body’s ability to rebuild and maintain bone mass.

 

In addition, chemotherapy can alter the bone marrow environment, where critical signaling pathways for bone regeneration originate. The result is a compounded effect: decreased bone formation, increased vulnerability to microdamage, and impaired recovery from routine stress.

Another pathway involves treatment-induced hypogonadism. Certain chemotherapies can damage the testes, reducing testosterone production even after treatment has ended. This secondary hormonal deficiency can persist long-term, placing survivors at continued risk for accelerated bone loss well into survivorship.

 

The Role of Supportive Medications

Glucocorticoids—commonly prescribed alongside chemotherapy to manage inflammation, nausea, or immune-related complications—represent another significant threat to bone health. These medications impair calcium absorption, suppress osteoblast function, and increase bone resorption.

 

Over time, chronic exposure to steroids can produce rapid and substantial declines in bone density. This effect is particularly concerning when layered on top of other treatment-related risks, creating a cumulative burden on skeletal integrity.

 

Quantifying the Risk: Bone Loss and Fractures

Clinical observations consistently show that men undergoing cancer treatment may experience accelerated declines in bone mineral density—sometimes at rates far exceeding those seen in age-related osteoporosis. The hip and lumbar spine, both critical weight-bearing regions, are especially vulnerable.

 

This loss is not merely a laboratory finding. It translates into real-world consequences: increased susceptibility to fractures, prolonged recovery times, and, in many cases, permanent reductions in mobility. For older patients, a single fracture—particularly of the hip—can mark a turning point toward loss of independence and overall health decline.

 

Importantly, these risks are not confined to active treatment periods. Many cancer survivors continue to face elevated fracture risk years after therapy has concluded, underscoring the need for long-term monitoring.

 

 

Early Detection: A Missed Opportunity

Despite the clear association between cancer therapies and bone loss, screening is often underutilized. Tools such as DEXA scan (dual-energy X-ray absorptiometry) provide a noninvasive and highly accurate method for assessing bone mineral density. Yet many patients do not receive baseline or follow-up evaluations.

Emerging imaging approaches—including advanced ultrasound techniques and metabolic bone markers—are beginning to offer additional insight into bone quality and turnover. These modalities may play an increasingly important role in identifying early changes before significant loss occurs.

 

The principle is simple: what is not measured cannot be managed. Incorporating routine bone health assessments into cancer care protocols represents a critical step toward prevention.

 

Prevention and Intervention: Rebuilding Strength from Within

The good news is that treatment-related bone loss is not inevitable. With proactive management, patients can significantly reduce their risk of osteoporosis and fractures.

 

Lifestyle strategies form the foundation of prevention. Weight-bearing and resistance exercises stimulate bone formation and improve muscular support, reducing fall risk. Nutritional optimization—including adequate intake of calcium and vitamin D—supports skeletal health at a biochemical level.

Pharmacologic interventions also play a role. Medications such as bisphosphonates and other bone-modifying agents can help slow resorption and preserve bone density in high-risk patients. When used appropriately, these therapies can stabilize or even improve bone metrics over time.

 

Equally important is addressing hormonal balance. In select cases, careful evaluation of testosterone levels and endocrine function may guide additional supportive strategies.

 

A Call for Integrated Care

The link between cancer treatment and osteoporosis highlights a broader issue in modern medicine: the need for integrated, whole-patient care. Survival is no longer the sole endpoint. Quality of life, functional independence, and long-term resilience must be part of the equation.

 

For clinicians, this means recognizing bone health as a core component of oncology care—not an afterthought. For patients, it means understanding that vigilance does not end when treatment concludes.

The skeleton tells a story—of strength, adaptation, and vulnerability. In the context of cancer therapy, it also tells a warning: that life-saving treatments can carry hidden costs. The challenge, and the opportunity, lies in addressing these risks early, intelligently, and comprehensively.

 

Because preserving life should never come at the expense of the very structure that supports it.

 

 Part 2

EARLY DETECTION OF OSTEOPOROSIS:

Seeing the Risk Before the Fracture

By Dr. Robert L. Bard, MD, DABR, FAIUM, FASLMS

Osteoporosis is often discovered too late—after a fracture, when the structural integrity of bone has already been compromised. In my clinical experience, the true opportunity lies not in reacting to fractures, but in identifying vulnerability years before they occur. Early detection transforms osteoporosis from a crisis into a manageable condition. The challenge is that bone loss is silent. Patients feel strong, active, and asymptomatic while microarchitectural deterioration quietly progresses beneath the surface. This is where imaging becomes essential—not just as a diagnostic tool, but as a predictive instrument.

The current gold standard for screening remains the dual-energy X-ray absorptiometry (DEXA) scan. It provides a quantitative measurement of bone mineral density (BMD) and assigns a T-score that helps stratify risk. DEXA is widely available, cost-effective, and invaluable for baseline assessment and longitudinal tracking. However, BMD alone does not tell the whole story. Bone strength is not just about density—it is also about quality, vascular supply, and structural integrity. This is where advanced imaging begins to fill critical gaps.

Ultrasound, particularly high-resolution musculoskeletal ultrasound, is emerging as a powerful adjunct in early osteoporosis detection. Unlike DEXA, ultrasound allows real-time evaluation of cortical bone surfaces, periosteal irregularities, and surrounding soft tissue. More importantly, Doppler ultrasound can assess microvascular flow, offering insight into bone perfusion—an underappreciated factor in bone health. Reduced vascularity may precede measurable density loss, providing an earlier warning signal. In a precision-medicine model, this kind of functional imaging helps us detect risk before it becomes structural failure.

Other modalities also contribute to a more comprehensive picture. Quantitative computed tomography (QCT) provides three-dimensional assessment of bone density and can distinguish between cortical and trabecular bone compartments. This is particularly useful in complex or high-risk patients where subtle changes may be missed on DEXA. Trabecular Bone Score (TBS), often derived from DEXA data, adds another layer by estimating bone microarchitecture. Meanwhile, MRI—though not routinely used for screening—can reveal bone marrow changes and early insufficiency fractures in symptomatic patients.

Emerging technologies are pushing the boundaries even further. High-frequency ultrasound systems and elastography are being explored for their ability to assess bone stiffness and mechanical properties. These tools align with a broader shift in medicine: moving from static imaging to dynamic, functional evaluation. The goal is not simply to measure bone—but to understand its behavior under stress, its vascular support, and its capacity to withstand injury

Early detection must also be individualized. Patients with hormonal imbalances, thyroid disorders, cancer treatment histories, or chronic inflammatory conditions may require earlier and more nuanced screening strategies. Waiting until age-based guidelines trigger a DEXA scan may miss years of preventable decline. Imaging should be integrated with clinical risk factors, laboratory data, and lifestyle assessment to create a full risk profile.

Ultimately, the future of osteoporosis care is proactive. The tools already exist—we simply need to apply them earlier and more intelligently. By combining DEXA with advanced ultrasound, Doppler analysis, and complementary imaging technologies, we can identify bone vulnerability at its earliest stages. In doing so, we shift the conversation from fracture management to fracture prevention—preserving not just bone density, but independence, mobility, and quality of life.

STRESS IN MALE BREAST CANCER

 Why Emotional Health Must Be Part of Survivorship Care

Co-Written by Dr. Barbara Bartlik and Dr. Robert L. Bard

Cancer care has traditionally focused on surgery, chemotherapy, radiation, medications, and imaging. Yet one of the most powerful influences on health outcomes often receives far less attention: stress. According to integrative psychiatrist Dr. Barbara Bartlik and diagnostic imaging specialist Dr. Robert L. Bard, chronic stress and anxiety are not merely emotional burdens—they can become biological burdens that affect healing, immune resilience, inflammation, sleep quality, and quality of life.

Their message is clear: no cancer treatment plan is complete unless it addresses the mind and body together.

Understanding the Stress Response

Stress is the body’s natural alarm system. In short bursts, it can be useful. It helps us react to danger, sharpen focus, and mobilize energy. But when stress becomes chronic—as it often does during diagnosis, treatment, financial strain, uncertainty, or fear of recurrence—the body can remain trapped in a constant state of physiological alert.

This prolonged stress response activates the adrenal glands, which release cortisol and adrenaline. These hormones are helpful during emergencies, but harmful when elevated for long periods.

Persistently high cortisol has been associated with:

• Suppressed immune surveillance
• Increased inflammation
• Sleep disruption
• Insulin resistance
• Weight gain or muscle loss
• Mood instability
• Fatigue and burnout
• Impaired tissue repair

For someone navigating cancer or survivorship, these effects can be especially significant.

Stress and the Immune System

The immune system plays a central role in monitoring abnormal cells, fighting infection, and assisting recovery after treatment. Chronic anxiety may weaken this system by altering white blood cell function, inflammatory signaling, and restorative sleep cycles.

Dr. Bartlik emphasizes that emotional trauma, unresolved fear, depression, and persistent hypervigilance can keep the nervous system in “fight-or-flight” mode. When the body never fully returns to calm, healing resources are diverted away from restoration.

This does not mean stress “causes cancer” in a simplistic sense. Cancer is complex and multifactorial. Genetics, environment, lifestyle, exposures, hormones, and age all matter. However, unmanaged stress can aggravate biological terrain, worsen symptoms, and diminish the body’s ability to recover optimally.

Cortisol, Inflammation, and Disease Burden

Inflammation is one of the most discussed pathways in modern medicine. While acute inflammation helps healing, chronic inflammation may contribute to pain, metabolic dysfunction, vascular strain, mood disorders, and fatigue.

Stress hormones can intensify inflammatory cascades. Survivors often describe feeling “wired but tired”—an exhausted state marked by anxiety, poor sleep, racing thoughts, and low resilience. This is where psychiatry, lifestyle medicine, and rehabilitation can become powerful allies.

Dr. Bartlik advocates a whole-person approach that may include:

• Nutritional support
• Sleep restoration
• Mindfulness and breathing practices
• Trauma-informed therapy
• Exercise prescriptions
• Nutraceutical support when appropriate
• Medication when clinically indicated
• Social connection and purpose-building

The Cancer Diagnosis Itself Is a Stress Event

A cancer diagnosis is not only a medical event—it is a psychological earthquake. Even patients with excellent prognoses may experience panic, grief, anger, isolation, or catastrophic thinking. During treatment, many face body-image changes, pain, financial pressure, career uncertainty, and family strain.

After treatment ends, many expect life to return to normal. Instead, survivorship often brings a new challenge: silent anxiety. Fear of recurrence, ongoing fatigue, hormonal shifts, cognitive fog, and loss of confidence can linger for years.

This is where post-treatment rehabilitation becomes essential.

Survivorship Is More Than “Cancer-Free”

Dr. Robert L. Bard has long advocated that survivorship should not be measured only by whether visible disease is gone. It should also be measured by how the patient functions physically, mentally, hormonally, socially, and emotionally.

He argues that many survivors are declared “finished” with treatment while still struggling with:

• Chronic fatigue
• Lymphedema
• Neuropathy
• Brain fog
• Anxiety and depression
• Loss of strength
• Sleep disorders
• Pain syndromes
• Hormonal imbalance
• Deconditioning
• Fear of movement

These are rehabilitation issues—and they deserve clinical attention.

How Rehabilitation Reduces Stress Biology

Cancer rehabilitation is one of the most underutilized tools for stress reduction. When survivors regain function, movement, strength, and confidence, the nervous system often shifts out of chronic threat mode.

Dr. Bard supports multidisciplinary survivorship rehab that may include:

• Physical therapy
• Strength training
• Balance and fall-prevention work
• Lymphedema therapy
• Massage and myofascial care
• Cognitive rehabilitation
• Nutritional counseling
• Integrative psychiatry
• Sleep medicine
• Mind-body coaching

Movement itself can be medicine. Exercise has been shown to support mood regulation, insulin sensitivity, sleep quality, circulation, and inflammatory balance. Even walking programs, resistance bands, yoga, tai chi, or supervised recovery exercise can create profound gains.

Imaging, Insight, and Personalized Recovery

As a diagnostic imaging specialist, Dr. Bard emphasizes that recovery should be personalized, not generic. Advanced imaging can help identify inflammation, vascular compromise, musculoskeletal strain, scar tissue behavior, or other treatable contributors to pain and dysfunction.

When patients understand why they hurt or where limitations exist, anxiety often decreases. Information reduces fear. Objective findings can guide smarter rehabilitation plans and provide measurable progress markers.

The Emotional Side of Healing

Dr. Bartlik notes that healing requires safety. Patients who feel heard, supported, and empowered often do better emotionally than those who feel dismissed or rushed. Compassionate medicine lowers stress. Human connection matters.

Support groups, counseling, spiritual care, journaling, creative arts, and relationship repair can all become part of survivorship medicine. There is no single path—but there should always be a path.

A New Standard of Care

Stress and anxiety should no longer be considered side issues in oncology. They are central variables affecting resilience, adherence, sleep, inflammation, mood, and recovery capacity. The future of cancer care is integrated care—where oncologists, imaging specialists, psychiatrists, rehab teams, nutrition experts, and exercise professionals work together.

As Drs. Bartlik and Bard would agree: surviving cancer is not the finish line. Restoring peace, strength, confidence, and quality of life is where the next chapter begins.

 

"WAS I FIRED BECAUSE OF CANCER?" (Draft only- not for distribution)

The Hidden Employment Crisis Potentially Facing Cancer Patients

 A Social Commentary By: Lennard M. Goetze, Ed.D / Barbara Bartlik, MD

Disclaimer: This commentary does not suggest that employers openly terminate workers because they have cancer. In most cases, employment actions are tied to broader issues such as prolonged absences, repeated medical leave, reduced availability, performance disruption, staffing pressures, or disputes over accommodations during treatment. However, as reports and legal complaints continue to surface, serious illness—particularly cancer requiring extensive time away from work—can place employees in a vulnerable position where their job security may be jeopardized. This social commentary examines that growing concern: the intersection of health hardship, workplace pressures, and the need for fairer protections for individuals managing life-threatening disease while trying to remain employed.

Cancer changes everything in a moment. It alters health, finances, family dynamics, and emotional stability. Yet for many patients, another crisis quietly emerges after diagnosis: the fear of losing their job. While public conversations often focus on treatment and survival, far less attention is given to employment vulnerability—the growing pattern of workers being sidelined, pressured out, or terminated after serious illness.

Advocates describe it as one of the most overlooked burdens of cancer care. Four-time cancer survivor and patient advocate SCOTT BAKER has seen it firsthand. Through years of supporting patients and families, he says many workers discover that the moment they need compassion most is when job security becomes uncertain.

“There are certain businesses where it’s just too much time off,” Baker explained. “They need you to be a ten out of ten every day, so they say, we can’t keep you.”  This is not simply an HR issue. It is a public health concern, an economic concern, and increasingly, a legislative concern.

 

The Unspoken Pattern of Employment Risk

Many workers assume that once diagnosed with cancer, legal systems automatically shield them from termination. The reality is more complicated. Some protections exist under disability and leave laws, but they are often narrow, time-limited, or dependent on company size, job tenure, and documentation requirements. That leaves countless employees exposed.

Baker recalled cases involving young nurses who had been employed for less than a year when they were diagnosed. Because they had not yet qualified for leave protections, they were let go. “They didn’t qualify for FMLA, so they just let them go,” he said.

Healthcare workers themselves are not immune. In fact, Baker emphasized that hospitals and medical institutions can reflect the same pressures seen in other industries—staffing shortages, productivity demands, and limited tolerance for extended absence. For patients, the message can feel brutal: get well quickly, or become replaceable.

Even After Treatment, the Battle Continues

One of the least understood realities of cancer recovery is that treatment completion does not equal full recovery. Many survivors return to work carrying fatigue, neuropathy, cognitive fog, anxiety, chronic pain, or emotional trauma. “They come back, and they’re not the same,” Baker noted. “It takes a long time to recover.”

This creates a dangerous gap. Employers may expect immediate peak performance, while survivors are still rebuilding physically and mentally. In fast-paced or high-output environments, workers may be quietly managed out, demoted, or judged against pre-illness standards. The result is a second trauma layered on top of the first.

 

The Self-Employed Face a Different Crisis

For entrepreneurs, freelancers, and small business owners, illness can be even more devastating. There may be no paid leave, no corporate benefits, and no substitute income stream. “They go from breadwinner to no bread,” Baker said bluntly.  This group often falls through policy cracks. They are workers without the protections many traditional employees assume exist.

 

What Can Be Done Legislatively?

Advocates increasingly argue that cancer survivorship must include employment security. Several reforms could make a meaningful difference:

1. Expand Medical Leave Eligibility: Current leave laws often exclude newer employees, part-time workers, or workers in smaller companies. Reform should shorten waiting periods and broaden eligibility for serious illness.

2. Modernize Temporary Disability Benefits: Baker recently advocated for reform of temporary disability insurance, noting that some benefit levels remain shockingly outdated. “$189 a week is not cutting it,” he said. For many families, that amount would not cover transportation to treatment, let alone rent or groceries.

3. Protect Return-to-Work Rights: Legislation could require reasonable phased returns, flexible scheduling, and medical accommodation for cancer survivors re-entering the workforce.

4. Strengthen Anti-Retaliation Enforcement: Some workers are not formally fired—they are squeezed out through reduced hours, negative reviews, or hostility after disclosure. Better enforcement mechanisms are urgently needed.

5. Incentivize Retention: Tax credits or subsidies for employers who retain and accommodate workers undergoing treatment could turn compassion into practical policy.

Work-Arounds for Workers Right Now

Until laws catch up, patients need strategies:

·   Disclose medical issues carefully and document all communications.

·   Request accommodations in writing.

·   Understand leave rights under federal and state law.

·   Consult employment attorneys or patient advocacy groups early.

·   Build relationships with supervisors who may advocate internally.

Baker credits a supportive supervisor with helping save his own position during prolonged treatment. Without that ally, the outcome may have been very different.  That should not depend on luck.

A Larger Moral Question

How a society treats workers during illness reveals its values. Cancer patients are not disposable assets. They are teachers, nurses, tradespeople, executives, parents, veterans, and community members fighting for their lives. To punish illness with unemployment is not efficiency—it is failure.

 

Conclusion

The hidden employment crisis facing cancer patients deserves national attention. Behind many survival stories lies another story of lost income, lost dignity, and preventable hardship. The goal of modern medicine is not merely to keep people alive—it is to preserve their ability to live.

Scott Baker’s warning is clear: the risk is real, widespread, and often invisible. The next frontier of survivorship is not only better treatment. It is better protection. No one battling cancer should also have to battle for the right to keep their job.

 

PART 2: CLINICAL PERSPECTIVE

WORK IS MEDICINE: WHY A CANCER DIAGNOSIS SHOULD NOT END A PERSON’S CAREER

Written by Dr. Robert L. Bard

I have spent my professional life studying disease through imaging, diagnostics, and the realities of patient care. Over decades of working with cancer patients, I have learned one truth that too many employers fail to understand: a cancer diagnosis does not automatically mean disability, incapacity, or the end of productivity.

That is why I stand in full support of the concerns raised by Scott Baker in his important discussion about workers being fired because of cancer. This issue is real, it is harmful, and in many cases, it is based on fear rather than fact. Too often, people are judged by a diagnosis instead of their actual condition, their strength, or their ability to contribute. As physicians, employers, and as a society, we must do better.

The Diagnosis Is Not the Disability

One of the greatest misconceptions in the workplace is the belief that once a person hears the word “cancer,” they are no longer able to function. This is medically inaccurate. Many cancers today are treatable, manageable, slow-growing, or responsive to therapy. Some remain stable for years or decades.

I have personally followed patients with low-grade prostate cancer who continue to live normal, active, productive lives. With modern imaging, surveillance, and appropriate care, we can often confirm that their condition has not progressed and does not impair their daily function.

I have also known patients with metastatic disease who still climb stairs, go to work, care for families, and remain deeply engaged in life. Their diagnosis did not define their usefulness. Their resilience did.

Work Can Be Healing

Employment is not only about income. Work gives structure, purpose, identity, dignity, and hope. For many patients, returning to work or continuing to work becomes part of recovery. It restores normalcy during a frightening time. It reminds them they are still needed.

I recall experiencing severe postoperative pain years ago after a dental procedure. The discomfort was so intense that I went back to work simply to focus my mind on something productive rather than on suffering. That experience taught me that meaningful activity can help redirect pain, anxiety, and despair. Cancer patients deserve that same opportunity.

The Role of Medical Verification

Today we have advanced tools that can help objectively assess a patient’s status. Through ultrasound imaging, Doppler flow studies, elastography, and other noninvasive technologies, we can monitor tumor behavior, treatment response, and physical function.

This means decisions about employment should not be based on assumptions or stigma. They should be based on facts. If a patient is medically capable of working, physicians should feel empowered to document that reality. Employers should welcome that guidance rather than fear it.

A Special Concern: Healthcare Workers

I was especially troubled to hear reports of nurses and healthcare workers losing jobs soon after a diagnosis. That is not only unjust—it is counterproductive.

When a nurse with cancer continues to serve with strength and professionalism, it sends a powerful message to every patient in that hospital: survival is possible, life continues, and illness does not erase value. Those workers become living symbols of courage. To remove them because “it doesn’t look good” is a failure of compassion and leadership.

Final Word

A cancer diagnosis should trigger support, not suspicion. It should lead to accommodation where needed, not automatic termination. We need stronger workplace protections, physician-backed return-to-work pathways, and a national understanding that many people with cancer can continue to live and work successfully.

Cancer is a health challenge. It should never become an employment sentence.

 

 

NEWS REFERENCES:

1. United Airlines Employee Claims He Was Fired Mid-Chemo Session: A United Airlines worker with stage 4 lymphoma alleged he was fired over the phone during chemotherapy for “taking too much time off work.” Read People Magazine Report

---

2. Independent Report on Same United Airlines Lawsuit: Detailed coverage of the federal complaint, including allegations he continued working while undergoing treatment. Read The Independent Report

---

3. Black Enterprise Coverage: Fired After Using PTO for Chemotherapy: Follow-up reporting focused on the use of accrued leave for cancer treatment and alleged termination. Read Black Enterprise Report

---

4. Nurse Alleges Firing While Fighting Breast Cancer: Public reporting described a nurse claiming termination after requesting leave connected to surgery and treatment. (Referenced in prior public reports.) Search Related Public Coverage

---

5. Workers Losing Jobs Before FMLA Eligibility: The United complaint alleges termination one week before the employee qualified for federal protected leave. Read FMLA Allegation Details

---

6. National Pattern: Cancer Patients Reporting Employment Retaliation- This case has drawn public attention because it reflects a broader pattern of workers claiming punishment after serious diagnoses. Read National Discussion Coverage

---

7. Lawsuit Includes ADA Disability Discrimination Claims: The complaint reportedly includes violations under the Equal Employment Opportunity Commission framework and disability law standards. Read Legal Allegations

---

8. “No One Should Have to Choose Between Health and Livelihood”: The employee’s attorney framed the case as forcing workers to choose between treatment and employment. Read Attorney Statement

MBCGA Inducts Two Powerful Champions of Survivorship & "Exercise for Cancer Recovery"

 Male Breast Cancer Global Alliance Honors Two Champions of Survivorship, Advocacy and Recovery

In a spirited and highly meaningful leadership meeting, the Male Breast Cancer Global Alliance (MBCGA) formally recognized two distinguished men whose lives and work embody courage, compassion, and action in the cancer survivorship movement: Scott Baker and Dr. Jay Harness.

Hosted by MBCGA President and CEO Cheri Ambrose, the virtual gathering brought together voices from medicine, publishing, advocacy, and survivorship to celebrate the appointments of these two men into key leadership roles. Lennard Goetze moderated the event, while emphasizing a new and growing mission: the launch of a broader movement focused on Male Breast Cancer Rehabilitation and Restorative Care.

 

Leadership Appointments Rooted in Service

The meeting opened with Cheri Ambrose announcing that Dr. Harness had been invited to join the MBCGA Medical Advisory Board, an invitation he warmly accepted. His decades of surgical oncology leadership, global reputation, and groundbreaking advocacy for exercise oncology made him an ideal addition to the organization’s expanding medical team.

 

Soon after, Scott Baker was officially invited to serve as Community Outreach Ambassador, recognizing his tireless grassroots support of patients, survivors, and families navigating the cancer journey. Baker also received notice of a special award to be presented later in the season for his humanitarian volunteerism and bedside advocacy.  “These appointments are based on merit, achievements, and proven volunteerism,” Ambrose noted. “We need leaders who understand survivorship not only professionally—but personally.”

 

Nomination of 2026 Leaders in Survivorship

Though unable to attend the meeting because of active patient-care responsibilities, Dr. Robert Bard was repeatedly acknowledged as the principal force behind the nomination of both honorees. Even in his absence, his presence was strongly felt throughout the discussion, as speakers referenced his judgment, leadership, and unwavering commitment to advancing survivorship through meaningful action. Those who know Bard understand that he does not offer endorsements casually. When he supports an individual for leadership, it is rooted in observed merit, measurable contribution, and a genuine belief that the person can elevate the mission.

Lennard Goetze explained that Bard “hands down” championed the appointment of Dr. Jay Harness to the Medical Advisory Board. Bard recognized in Dr. Harness not only an accomplished surgeon and respected international authority, but also a physician who has continued to serve long after retirement through education, mentorship, and public advocacy. In particular, Bard admired Harness’s tireless promotion of exercise oncology—a field transforming how clinicians view movement, strength, and rehabilitation during the cancer journey. To Bard, this was not simply a wellness topic; it was an essential component of modern survivorship medicine.

At the same time, Bard strongly supported the induction of Scott Baker into a leadership role in community outreach. Baker’s value, in Bard’s eyes, comes from something no credential alone can provide: lived experience forged through repeated battles with cancer. Bard has long respected survivors who turn pain into purpose, and Baker’s willingness to guide others, encourage patients, and stand beside those in fear represented exactly the kind of servant leadership the organization seeks. His compassion is practical, credible, and deeply human.

Together, these nominations reveal Bard’s broader philosophy of care. He believes the future of oncology must go beyond removing tumors or completing treatment protocols. True victory includes helping patients reclaim strength, dignity, confidence, mobility, emotional stability, and hope. In Dr. Harness, Bard saw the science and strategy of survivorship. In Scott Baker, he saw the heart and humanity of survivorship. By advancing both men, Bard effectively endorsed a new model of cancer leadership—one where medicine and mentorship stand side by side, and where quality of life is recognized as the next frontier of healing.

 

Exercise Oncology Takes Center Stage

One of the most compelling and forward-looking themes of the meeting was the rising importance of exercise oncology—a rapidly expanding discipline grounded in scientific evidence that uses movement, resistance training, cardiovascular conditioning, and guided physical activity to improve outcomes for people living with and recovering from cancer. What was once dismissed as a secondary lifestyle suggestion is now being recognized as an essential pillar of supportive cancer care. Throughout the discussion, participants made it clear that survivorship cannot be fully addressed without confronting the physical decline, fatigue, weakness, emotional strain, and loss of function that so often follow diagnosis and treatment.

At the center of this conversation was Dr. Jay Harness, who spoke with conviction about more than thirty years of accumulating research demonstrating that exercise can positively influence clinical outcomes across multiple cancer populations. His remarks reflected both scientific authority and practical wisdom. He emphasized that the data are no longer speculative or fringe. Study after study has shown that properly guided exercise can improve stamina, preserve lean muscle mass, reduce treatment-related fatigue, enhance emotional well-being, support metabolic health, and help many patients tolerate therapies more effectively.

“Exercise is medicine,” he stated. That phrase became one of the defining messages of the meeting. Dr. Harness explained that movement creates a cascade of beneficial physiologic responses throughout the body. Exercise can stimulate immune surveillance, improve circulation, enhance oxygen delivery to tissues, and support glucose regulation and insulin sensitivity. It can help counter the deconditioning that often accompanies chemotherapy, radiation, surgery, hormonal therapy, or prolonged inactivity. In many ways, it represents a therapeutic intervention hiding in plain sight.

He further noted that the benefits are not only muscular or cardiovascular. Physical activity activates powerful neurochemical responses that can directly influence morale and mental health. Endorphins, dopamine, serotonin, and other so-called “happy hormones” can elevate mood, reduce anxiety, and restore a sense of motivation at a time when many survivors feel emotionally depleted. Yet Dr. Harness stressed that these feel-good effects are only one part of a much larger biological story. Exercise also impacts inflammatory pathways, cellular signaling systems, mitochondrial efficiency, and other mechanisms linked to healing, resilience, and recovery.

As founder of Cancer Fitness, Dr. Harness has become an influential voice helping patients, clinicians, and advocacy groups rethink what rehabilitation can look like after cancer. His mission is not simply to encourage people to move more—it is to help integrate structured, intelligent movement into the cancer care continuum itself.

The meeting made one point unmistakably clear: exercise is no longer an optional side note in survivorship. It is becoming a frontline strategy for restoring strength, confidence, independence, and quality of life.

 

Scott Baker: Survivor Wisdom with Real-World Truth

If Dr. Harness represented the scientific case for survivorship movement, Scott Baker represented the human case. A four-time cancer survivor, Baker spoke candidly about the emotional barriers many men face when illness strips away independence.

 

“There’s nothing wrong with asking for help,” he said. “It doesn’t make you weak.” He noted that many men avoid support groups, rehab programs, and public discussion because they wrongly associate vulnerability with weakness. Yet his own journey taught him that healing begins when pride ends.

 

One of the most memorable lines of the meeting came when Baker said: “It’s hard to be macho when you’re walking around in a backless hospital gown.” The comment brought laughter—but also truth. Cancer humbles everyone. Baker’s honesty and humor illustrated exactly why MBCGA leaders saw him as a model spokesperson for men who need permission to seek support.

 

Challenging Bias Around Male Breast Cancer

Another major topic was the ongoing stigma surrounding male breast cancer itself. Goetze emphasized that male breast cancer remains underdiagnosed partly because many men do not want to acknowledge symptoms, undergo screening, or publicly discuss a disease culturally labeled as female.

 

“Stop the bias” has become a rallying message for MBCGA. The organization believes earlier detection, public education, and open conversations can save lives. Baker and Harness were praised as the kind of visible male leaders who can help dismantle silence and embarrassment.

 

A New Movement: Rehabilitation and Restoration

Goetze also introduced a new strategic segment under the MBCGA umbrella: Male Breast Cancer Rehab and Restorative Movement. This initiative promotes a broader understanding of survivorship—not merely living after treatment, but living well after treatment. That means attention to:

• strength rebuilding
• fatigue recovery
• emotional resilience
• body confidence
• hormonal health
• social connection
• exercise programming
• return to purpose and identity

As Ambrose said during the discussion, many survivors are searching for “some sense of normal”—even if it becomes a “new normal.”

 

A Global Future

Dr. Harness also accepted an invitation to speak at the MBCGA Global Medical Summit this October, further strengthening ties between the alliance and the worldwide exercise oncology movement. Participants discussed future podcasts, publishing collaborations, firefighter outreach programs, advocacy campaigns, and cross-promotional education that can bring survivorship tools to more people internationally.

 

Conclusion

This was more than an appointment meeting—it was a declaration of direction. By inducting Scott Baker and Dr. Jay Harness into leadership, the Male Breast Cancer Global Alliance signaled that the future of cancer advocacy must include not only awareness and treatment—but rehabilitation, exercise, emotional healing, and restored quality of life. Two men were honored. But countless survivors stand to benefit.